Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy
- 1 June 1996
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 174 (6), 1917-1924
- https://doi.org/10.1016/s0002-9378(96)70229-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- 5-Day Methotrexate for Women with Metastatic Gestational Trophoblastic DiseaseGynecologic Oncology, 1994
- Metastatic gestational trophoblastic disease: A comparison of prognostic classification systemsGynecologic Oncology, 1992
- Correlation of plasma methotrexate concentration with human chorionic gonadotropin and therapeutic response to low-dose methotrexate-citrovorum factor in low-medium-risk gestational trophoblastic tumorsGynecologic Oncology, 1991
- The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)BJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Role of Computed Axial Tomography of the Chest in Staging Patients With Nonmetastatic Gestational Trophoblastic DiseaseObstetrics & Gynecology, 1986
- Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic diseaseGynecologic Oncology, 1986
- Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1984
- FOLLOW‐UP AFTER HYDATlDIFORM MOLE: STUDIES USING RADIOIMMUNOASSAY FOR URINARY HUMAN CHORIONIC GONADOTROPHIN (HCG)BJOG: An International Journal of Obstetrics and Gynaecology, 1973
- INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURSBJOG: An International Journal of Obstetrics and Gynaecology, 1964
- Effect of Methotrexate Therapy upon Choriocarcinoma and ChorioadenomaExperimental Biology and Medicine, 1956